← Back to screener

KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS

Rank #1978 · Nasdaq · $1.7B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
37.3
P/E
-15.2
P/B
-8.28
ROE
54.4%
Op. Margin
-177.8%
Debt Ratio
-43%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -15.2x, P/B -8.28x. Ranks in the top 91% of the universe.

Profitability ★★★☆☆
Average

ROE 54.4%. Ranks in the top 50% of the universe.

Safety ★★★★★
Excellent

Debt ratio -43%. Ranks in the top 6% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★★
Excellent

Revenue growth of 115.1% year over year. Ranks in the top 3% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2025$0.0B$-0.1B$-0.1B$-0.1B-305.8-67
2026$0.1B$-0.1B$-0.1B$-0.2B-177.8-43

← See the full screener